- Q1 2024 Y-mAbs Therapeutics Inc Earnings Call TranscriptMay 08, 2024$13.61 (-20.92%)Earnings
- Q4 2023 Y-mAbs Therapeutics Inc Earnings Call TranscriptMar 01, 2024$18.69 (+11.92%)Earnings
- Y-mAbs Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Q3 2023 Y-mAbs Therapeutics Inc Earnings Call TranscriptNov 14, 2023$5.36 (+9.84%)Earnings
- Q2 2023 Y-mAbs Therapeutics Inc Earnings Call TranscriptAug 11, 2023$5.55 (-9.90%)Earnings
- Q1 2023 Y-mAbs Therapeutics Inc Earnings Call TranscriptMay 09, 2023$9.23 (+36.34%)Earnings
- Q4 2022 Y-mAbs Therapeutics Inc Earnings Call TranscriptMar 31, 2023$5.01 (+52.28%)Earnings
- Y-mAbs Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Y-mAbs Therapeutics Inc To Host Annual Research and Development Day TranscriptDec 14, 2022
- Q3 2022 Y-mAbs Therapeutics Inc Earnings Call TranscriptNov 08, 2022$3.89 (+16.12%)Earnings
- Q2 2022 Y-mAbs Therapeutics Inc Earnings Call TranscriptAug 09, 2022$17.89 (-4.33%)Earnings
- Q1 2022 Y-mAbs Therapeutics Inc Earnings Call TranscriptMay 10, 2022$10.03 (+22.02%)Earnings
- Q4 2021 Y-mAbs Therapeutics Inc Earnings Call TranscriptFeb 25, 2022$8.91 (+11.24%)Earnings
- Y-mAbs Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- Y-mAbs Therapeutics Inc Research And Development Day (Virtual) TranscriptDec 15, 2021
- Q3 2021 Y-mAbs Therapeutics Inc Earnings Call TranscriptNov 05, 2021$22.23 (-6.32%)Earnings
- Y-mAbs Therapeutics Inc to Host Key Opinion Leader Webinar on DANYELZA® - Conference Call TranscriptSep 23, 2021
- Q2 2021 Y-mAbs Therapeutics Inc Earnings Call TranscriptAug 06, 2021$29.25 (-21.60%)Earnings
- Q1 2021 Y-mAbs Therapeutics Inc Earnings Call TranscriptMay 07, 2021$34.2 (+19.37%)Earnings
- Full Year 2020 Y-mAbs Therapeutics, Inc Earnings Call TranscriptFeb 26, 2021$35.17 (+4.42%)Earnings
- Y-mAbs Therapeutics, Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- Y-mAbs Therapeutics, Inc. - Special Call TranscriptDec 16, 2020
- Q3 2020 Y-mAbs Therapeutics, Inc Earnings Call TranscriptNov 06, 2020$47.32 (-2.83%)Earnings
- Y-mAbs Therapeutics, Inc. - Special Call TranscriptOct 06, 2020
- Q2 2020 Y-mAbs Therapeutics, Inc Earnings Call TranscriptAug 07, 2020$38.03 (-4.33%)Earnings
- Y-mAbs Therapeutics, Inc Annual Shareholders Meeting TranscriptJun 11, 2020
- Q1 2020 Y-mAbs Therapeutics, Inc Earnings Call TranscriptMay 08, 2020$39.84 (+12.51%)Earnings
- Q4 2019 Y-mAbs Therapeutics, Inc Earnings Call TranscriptMar 12, 2020$19.66 (-14.45%)Earnings
- Y-mAbs Therapeutics, Inc at JPMorgan Healthcare Conference TranscriptJan 16, 2020
- Y-mAbs Therapeutics, Inc. - Special Call TranscriptDec 11, 2019
- Q3 2019 Y-mAbs Therapeutics, Inc Earnings Call TranscriptNov 13, 2019$28.68 (+0.46%)Earnings
- Q2 2019 Y-mAbs Therapeutics, Inc Earnings Call TranscriptAug 14, 2019$26.16 (+1.32%)Earnings
Y-mAbs Therapeutics, Inc. - Special Call Transcript
Greetings, and welcome to the Y-mAbs Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host for today's conference, Dr. Claus Møller. Thank you, Doctor. Please go ahead.
¸ -
Thank you very much. Good morning, everybody, and thanks for joining us today. I'm joined today by Y-mAbs Founder, Chairman and President, Thomas Gad; and our Chief Financial Officer, Bo Kruse. We are holding this call to provide an update of securing regulatory status for omburtamab. We completed the rolling submission for the BLA for omburtamab for the treatment of pediatric patients with CNS/leptomeningeal metastasis from neuroblastoma in August this year. And late on Friday, October 2, we received refusal -- a refusal to file a letter from the FDA.
Upon its preliminary review, the FDA determined that certain parts of the CMC module and the clinical module of the BLA required further detail to
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)